Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Rafael Winograd

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4304-3724; OpenAlex author ID A5011736012. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 6

  1. Surgical Resection of Murine PDAC Alters Hepatic Metastases and Immune Microenvironment. Co-author DOI 10.1097/mpa.0000000000002516↗
  2. Alliance A022106: A Phase II/III Trial of Nab-Paclitaxel and Gemcitabine ± Cisplatin as Second-Line Treatment for BRCA1/2 or PALB2 Mutant Metastatic Pancreatic… Co-author DOI 10.1200/oa-25-00099↗
  3. Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer. Co-author DOI 10.1016/j.ccell.2022.05.006↗
  4. A novel target for combination immunotherapy in pancreatic cancer: IL-1β mediates immunosuppression in the tumour microenvironment. Co-author DOI 10.1038/s41416-021-01303-2↗
  5. Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. Co-author DOI 10.1172/jci.insight.88328↗
  6. CD40 immunotherapy for pancreatic cancer. Co-author DOI 10.1007/s00262-013-1427-5↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dafna Bar‐Sagi · 3 shared papers, 2021–2025 · strength 0.55
  2. Emma Kurz · 2 shared papers, 2022–2025 · strength 0.32
  3. Andrew H. Ko · 1 shared paper, 2025 · strength 0.22
  4. Eric Andrew Collisson · 1 shared paper, 2025 · strength 0.22
  5. Mike Cusnir · 1 shared paper, 2025 · strength 0.22
  6. Eileen Mary O'Reilly · 1 shared paper, 2025 · strength 0.22
  7. Raymond Couric Wadlow · 1 shared paper, 2025 · strength 0.22
  8. Erica S. Tsang · 1 shared paper, 2025 · strength 0.22
  9. Gregory P. Botta · 1 shared paper, 2025 · strength 0.22
  10. Kenneth P. Olive · 1 shared paper, 2025 · strength 0.22
  11. Diane M. Simeone · 1 shared paper, 2021 · strength 0.22
  12. Anthony M Sorrentino · 1 shared paper, 2025 · strength 0.20
  13. Sarah R. Kaslow · 1 shared paper, 2025 · strength 0.20
  14. Christopher L. Wolfgang · 1 shared paper, 2025 · strength 0.20
  15. Ammar A. Javed · 1 shared paper, 2025 · strength 0.20
  16. An Ngo‐Huang · 1 shared paper, 2022 · strength 0.12
  17. Nathan H. Parker · 1 shared paper, 2022 · strength 0.12
  18. Keri Schadler · 1 shared paper, 2022 · strength 0.12
  19. Matthew H. G. Katz · 1 shared paper, 2022 · strength 0.12
  20. Sumedha Pareek · 1 shared paper, 2022 · strength 0.12
  21. Maria Q. B. Petzel · 1 shared paper, 2022 · strength 0.12
  22. Chirayu Mohindroo · 1 shared paper, 2022 · strength 0.12
  23. George Miller · 1 shared paper, 2022 · strength 0.12
  24. Florencia M. McAllister · 1 shared paper, 2022 · strength 0.12
  25. Rebecca A. Evans · 2 shared papers, 2013–2016 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.